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Abstract
Background: There is great interest about the possible contribution of ER stress to the apoptosis of pancreatic beta cells in
the diabetic state and with islet transplantation.
Methods and Findings: Expression of genes involved in ER stress were examined in beta cell enriched tissue obtained with
laser capture microdissection (LCM) from frozen sections of pancreases obtained from non-diabetic subjects at surgery and
from human islets transplanted into ICR-SCID mice for 4 wk. Because mice have higher glucose levels than humans, the
transplanted beta cells were exposed to mild hyperglycemia and the abnormal environment of the transplant site. RNA was
extracted from the LCM specimens, amplified and then subjected to microarray analysis. The transplanted beta cells showed
an unfolded protein response (UPR). There was activation of many genes of the IRE-1 pathway that provide protection
against the deleterious effects of ER stress, increased expression of ER chaperones and ERAD (ER-associated protein
degradation) proteins. The other two arms of ER stress, PERK and ATF-6, had many down regulated genes. Downregulation
of EIF2A could protect by inhibiting protein synthesis. Two genes known to contribute to apoptosis, CHOP and JNK, were
downregulated.
Conclusions: Human beta cells in a transplant site had UPR changes in gene expression that protect against the
proapoptotic effects of unfolded proteins.
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Introduction
Over the past 20 years the proof-of-principle of reversing the
diabetic state with islet transplantation has been established,
however, serious limitations remain [1]. Among other problems,
the grafts typically lose their efficacy within months to a few years,
they usually provide less than perfect glucose control, and the
availability of healthy islets for these transplants is very limited.
There are indications that insulin secretion is impaired in a
transplant site compared to that from beta cells in their native
environment [2]. There seems to be little capacity for regeneration
and there is a presumed increase in the rate of apoptosis. These
problems can be partially attributed to the effects of host immune
rejection, autoimmunity, and immunosuppressive drugs. However,
glucose toxicity [3] and the abnormal transplant environment [4]
also are likely to contribute to the altered functional capacity of
transplanted beta cells. Similar processes have been implicated in
the pathogenesis of type 2 diabetes [5,6].
The endoplasmic reticulum (ER) stress response can protect
cells when the cell’s unfolded protein load exceeds the endoplas-
mic reticulum’s folding capacity. ER stress responses include
induction of ER chaperone proteins, translational attenuation, ER
associated protein degradation, and when ER stress is severe,
apoptosis [7]. ER stress responses have been linked to beta cell
failure in type 2 diabetes [8,9,10,11,12,13], but most of the
supportive studies have been performed with in vitro measure-
ments.
The ER stress response is regulated by levels of BiP (heat shock
70kDa protein 5, HSPA5, GRP78), an ER chaperone protein, free
in the endoplasmic reticulum. When the ER folding load is
increased, free BiP levels decrease and three ER stress pathways
are initiated:
1. IRE-1 (endoplasmic reticulum to nucleus signaling 1) splices
XBP-1 (X box binding protein-1) resulting in translation of
transcription factor XBP-1 and increased production of ER
chaperones and ERAD (ER-associated protein degradation)
proteins [7].
2. PERK (protein kinase-like endoplasmic reticulum kinase)
phosphorylates eIF2a (eukaryotic translation initiation factor
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stimulated translation of transcription factor ATF-4 (activating
transcription factor 4). ATF-4 initiates a cascade promoting
transcription of the pro-apoptotic factor CHOP (C/EBP
homologous protein, DDIT3) [7,14].
3. Transcription factor ATF-6 (activating transcription factor 6)
promotes transcription of chaperone proteins, pro-apoptotic
factor CHOP, ERAD associated proteins, and the PERK
inhibitor DNA-JC3 (P58IRK, HSP40) [7,15].
The IRE-1 pathway results mainly in cell adaptation and
increased protein folding capacity, while activation of PERK and
ATF-6 pathways lead to increased levels of pro-apoptotic
components.
The present study was undertaken to determine if ER stress
response mechanisms contribute to the dysfunction of human beta
cells in a transplant site exposed to mild hyperglycemia. Thus,
mRNA expression of beta cells from tissue obtained from non-
diabetic subjects at surgery was compared to that of human beta
cells transplanted under the kidney capsule of SCID mice in order
to examine the difference in gene expression of beta cells in their
native environment compared to the in an abnormal transplant
environment, similar to that found with successful clinical
transplants [16]. Nearly pure pancreatic beta cell populations
were isolated by laser capture microdissection, extracted for RNA
and subjected to microarray analysis. The results show an ER
stress response in these beta cells but indicate that it is likely
serving a protective role rather than a destructive one.
Methods
Ethics Statement
Tissue samples were obtained and records reviewed with IRB
approval from Partners Healthcare and Joslin Diabetes Center.
The study of the discarded human tissue and review of medical
records was considered exempt from informed consent by both of
these IRBs. The Joslin Animal Care Committee approved all
animal experiments (protocol #90-07).
Surgical specimens and patient information
Pancreas specimens were selected from seven non-diabetic
patients undergoing full or partial pancreatectomy for concern
about pancreatic cancer but in whom pathology demonstrated no
malignant lesions involving pancreas itself or evidence of
pancreatitis. At the time of surgery pieces of tissue were placed
in Tissue-Tek OCT (Sakura Finetek U.S.A., Inc., Torrance, CA),
frozen in chilled isopentane and stored at 280uC pending
sectioning. Medical records were reviewed for the presence or
absence of diabetes, complications of diabetes, treatment of
diabetes or concomitant medications known to directly alter
insulin secretion or sensitivity. Other parameters included: age,
height, weight, history of glycemia including glucoses, glycohe-
moglobin levels, and pancreas pathology diagnosis. Via review of
both the Partner’s Healthcare Research Patient Data Repository
and confirmatory review of anatomic pathology information
system records present in the Harvard/Partners Virtual Specimen
Locator, it was determined that none of the selected patients had a
history of diabetes or anti-diabetic drug use, and all determined
pre-surgical blood glucose levels were normal. The clinical
characteristics of the surgical patients are shown in Table 1.
Transplanted Islets
Pancreases from the New England Organ Bank were processed
in the Joslin Islet Cell Resource Center. Donor HO5-25 was a 35
year-old male with a gunshot wound to the head. He had no
history of diabetes, a BMI of 30.4, was in intensive care for three
days, and recorded glucoses ranged between 106–175 mg/dl.
Cold ischemia time for the pancreas was 5 hours. Donor HO6-16
was a 57 year-old male with a broken neck from a fall. He had no
history of diabetes, a BMI of 27.7, was in intensive care for 1.5
days and recorded glucoses ranged from 133–160. Cold ischemia
time for the pancreas was 6 hours. Islets were isolated using
standard techniques [17] from two cadaver donors and 500 islets
were transplanted under the kidney capsule of 6 non-diabetic
ICR-SCID mice. In both cases, islet purity was 80–90% and
viability was 90–95%. Blood glucose concentrations were
determined using a glucose meter (Precision QID; Abbott Labs,
Bedford, MA) with blood obtained from a snipped tail.
After 28 days, the mice were anesthetized, the islet grafts were
recovered and placed in cryomolds, embedded in Tissue-Tek
OCT (Sakura Finetek U.S.A., Inc., Torrance, CA), frozen in
chilled isopentane and stored at 280uC, pending sectioning at
8mm;the mice were then sacrificed.
Laser Capture Microdissection (LCM)
LCM was performed using a protocol modified for human
pancreatic tissue [18,19]. For the surgical specimens, frozen
pancreatic sections were dehydrated in 70% ethanol for
30 seconds, DEPC-treated water for 30 sec, 70% ethanol for
30 sec, 100% ethanol (rinsing), 100% ethanol twice for 1 min, and
xylene for 4 min. Immediately after the slides were completely air-
dried, LCM was performed using PixCell II Laser Capture
Microdissection System (Arcturus Engineering, Mountain View,
CA). LCM was performed under direct microscopic visualization
by melting thermoplastic films mounted on optically transparent
LCM caps (Arcturus) on selected populations of cells; b-cell rich
Table 1. Clinical characteristics of 7 surgical patients.
Gender Age BMI Blood Glucose (mg/dL) Diagnosis
M 81 23 92 Duodenal adenocarcinoma with metastasis to lymph nodes, but not pancreas.
M 60 24 85 Stage IIA bile duct carcinoma with focal infiltration of pancreas
F 67 26 Unknown Pancreatic mucinous cystadenoma
M 72 35 92 Invasive periampullary adenocarcinoma No pancreatic involvement.
M 72 22 81 Periampullary tubulovillous adenoma with focal high grade dysplasia.
F 57 24 90 Intraductal papillary pancreatic mucinous cyst without malignancy.
F 77 26 91 Intraductal papillary mucinous neoplasm
doi:10.1371/journal.pone.0011211.t001
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to not dissect tissue from any areas with abnormal histological
appearance. The laser power and pulse duration determined the
laser spot size. To obtain optimal size of the laser pulse, we set the
system parameters as follows: laser power, 35 mW; pulse duration,
3.0 msec; and spot size, 7.5 mm. The cells attached to the
thermoplastic transfer film were incubated with 10 mlo fa
guanidine thiocyanate and polyethylene glycol octylphenol ether-
based buffer for 30 min at 42uC. Each section typically had 3–10
islets, and each islet contained 2–4 clumps of intrinsic fluorescence
representing b-cells. On average, 6–7 sections were used to obtain
800 hits, which were needed to obtain sufficient RNA for the
array. This minimum laser spot size of 7.5 mm allows collection of
tissue from only a few cells. LCM on the transplanted islet tissue
grafts was performed in an identical manner except the pulse
duration was 2.5 msec and the thermoplastic film contained about
500 hits of the microdissected cells. For both pancreatic and graft
dissections, each LCM session was completed within 30 minutes to
avoid RNA degradation.
RNA extraction, amplification biotinylation and GeneChip
processing
Total RNA was isolated using PicoPure RNA Isolation Kit
(Arcturus) and amplified by T7-based linear amplification using
T7-oligo-dT-primers. RNA amplifications were performed using
RiboAmp HS RNA Amplification Kits (Arcturus) following the
manufacture’s protocol. Amplified RNA (aRNA) quantity was
evaluated spectro-photometrically by readings at 260 nm (A260)
and 280 nm (A280). RNA quality was assessed by running 100 ng
of aRNA on Nano LabChip of Agilent 2100 Bioanalyzer (Agilent
Technologies, Inc., Santa Clara, CA). Amplified RNA was
converted into double-stranded complementary DNA (cDNA)
using the RiboAmp HS RNA Amplification Kit (Arcturus), and
biotinylated complementary RNA (cRNA) was generated from
cDNA by in vitro transcription reaction using the BioArray High
Yield RNA Transcript Labeling Kit (Enzo Diagnostics, Farming-
dale, NY). RNA products were purified using the MiraCol
TM
Purification Columns (Arcturus). Biotinylated cRNA was frag-
mented to nucleotide stretches of 30–200 nucleotides and
hybridized to the GeneChip Human X3P Array (Affymetrix,
Santa Clara, CA) after the quality of the labeled cRNA was
checked by GeneChip test array. The GeneChip X3P array
contains 61,000 probe sets representing 47,000 transcripts and
variants, including approximately 38,500 well-characterized
human genes. The probe arrays were washed and stained using
the Fluidics Station 400 and scanned using the Affymetrix Gene
Chip Scanner 3000 (Gene Chip Expression Analysis Technical
Manual, Affymetrix). Microarray experiments were run at the
Genomics Core of the Joslin Diabetes Center.
Microarray data analysis
Array data were normalized and comparisons were performed
using the DNA-Chip Analyzer (dChip) software (Harvard School
of Public Health, Boston, MA). dChip software implements
invariant set normalization and probe-level model-based expres-
sion analysis on multiple arrays, and computes the t-statistic and
the p-value based on the t-distribution. Computation of standard
errors for expression indexes allows calculating confidence
intervals for fold changes (33,34). Lower confidence bound
(LCB) and p-value were used to assess differentially expressed
genes using the cutoff 1.2 and p,0.05, respectively. All data will
be deposited in a MIAME compliant data base - accession number
pending.
Data analysis
Results are expressed as mean 6 standard error (SE).
Results
Blood glucose levels of mice
Glucose levels of mice with islet transplants ranged from
133 mg/dL to 178 mg/dL through 4 weeks. These values are high
for humans – in the impaired glucose tolerance range. The actual
levels in these mice may be even a little higher because clinical
glucose test strips give artifactually low values in rodents [20].
Even these mild elevations can cause glucotoxicity [6]. However,
blood glucose levels in this range approximate the mildly
hyperglycemic environment of islets in successful human islet
transplants [16]. Blood glucose data for recipient mice is shown in
Table 2.
IRE-1 Pathway
IRE-1 splices transcription factor XBP-1 mRNA to its active
form, resulting in additional translation of transcription factor
XBP-1, which increases expression of genes for ER chaperone
proteins and ER degradation proteins [7]. This pathway likely
serves a protective function for beta cells, helping to increase the
cell’s protein-folding capacity and ensuring quality control by
providing additional tools for degrading misfolded proteins [21]. A
number of the downstream targets of this pathway were
significantly upregulated in transplanted beta cells as compared
to surgical controls. Data for the IRE-1 pathway are contained in
Table 3. Upregulated gene expression of the following targets was
found: XBP-1; the chaperone proteins PDIA4 (protein disulfide
isomerase family A, member 4), Bip, and Grp94 (HSP90B1, heat
shock protein 90kDa beta); and the ER degradation proteins
(EDEM1, EDEM2). Some other genes involved with the ERAD
machinery [22], DERL1 (Der1-like domain family, member 1)
and DERL3, were down regulated. ERdj4 (DNAJB9, DnaJ
(Hsp40) homolog, subfamily B, member 9), which can inhibit ER
stress-induced apoptosis perhaps by aiding chaperone function
[23], was upregulated. DNA-JC3 was also upregulated. There was
no differential expression of WFS1, which is another IRE-1 target
[24]. Interestingly, JNK (c-jun N-terminal kinase), which is
activated by both the IRE-1, and XBP1 pathways [25] and has
been implicated in beta cell apoptosis and dysfunction [26], had
down regulated expression.
Table 2. Non-Fasting Blood Glucose of Recipient ICR-SCID
Mice.
Graft ID Donor ID No. of IEQ Blood Glucose (mg/dl)
IEQ 0D 14 D 28 D
1 H05-25 500 138 147 141
2 H05-25 500 169 177 163
3 H05-25 500 161 151 178
4 H06-16 500 142 158 114
5 H06-16 500 153 133 160
6 H06-16 500 139 142 126
Mean 150 151 147
Graft IDs represent separate transplants of 500 IE each. Donor ID refers to two
separate cadaver donors (H05-25 and H06-16). IEQ refers to islet equivalents.
Blood glucose values were determined on day 0 (pre-transplant), 14 and 28
after the transplants.
doi:10.1371/journal.pone.0011211.t002
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PERK is activated by decreasing levels of free BiP in the ER,
and is inhibited by DNAJC3 which acts to turn off this portion of
the ER stress response. PERK initiates two signal cascades. In the
first pathway, PERK phosphorylates eIF2a resulting in general-
ized attenuation of translation but with selectively increased
translation of transcription factor ATF-4. The transcriptional
cascade initiated by ATF-4 leads to transcription of ER chaperone
proteins (BiP), ER degradation associated gene products (HERP1,
HERP2), pro-apoptotic associated gene products such as C/EBP
homologous protein (CHOP, DDIT3) and proteins like GADD34
(PPP1R15A), which participate in feedback inhibition of the
cascade. This pathway also leads to transcriptional inhibition of
gene products involved in glucose metabolism (FBP, PEPCK, IRS-
2). In the second pathway, PERK activates NRF2 (nuclear factor
[erythroid-derived 2]-like 2), which turns on an antioxidant
response element signaling pathway [27], thus leading to
transcription of antioxidant gene products: glutathione S-transfer-
ase alpha 1(GSTA1), heme oxygenase-1 (HMOX1), Thioredoxin
(TXN), NAD(P)H dehydrogenase, quinone 1 (NQO1) and,
glutamate-cysteine ligase (GCLM) [7,14].
The gene expression data of the PERK pathway are contained
in Table 4. Both signal cascades initiated by PERK were
downregulated in the transplanted islets as compared to controls.
Both of PERK’s direct substrates, EIF2A and NRF2, showed
markedly reduced expression in transplanted islets. EIF2A
downregulation could be protective by inhibiting the production
of proteins that have folding problems. Two factors are activated
by stress to dephosphorylate EIF2A and attenuate protein
synthesis: GADD34 (PPP1R15A) and CReP (PPP1R15B) [28].
Expression of GADD34 was unchanged in the transplanted beta
cells, but that of CReP was markedly downregulated, which could
compensate for the reduction in EIF2A. The reduction in NRF2
could pose a threat through reduced expression of the antioxidant
genes GCLM, NQO1 and TXN. Expression levels of GSTA1 and
HMOX were unchanged.
Other downregulated genes included HERP2 (HEY2), insulin
receptor substrate 2 (IRS-2), CHOP and C/EBP-beta. Activation
of IRS-2 appears to have an antiapoptotic effect on beta cells [29].
However, the downregulation of CHOP, a key inducer of ER
stress induced apoptosis [14] and that of JNK suggest that ER
stress in this circumstance may not be detrimental to the survival
of transplanted beta cells. Moreover, C/EBP-beta, which is also
potentially proapoptotic, was also downregulated [30].
Various other genes thought to be targets of the PERK pathway
had no significant change of expression. These include the
following antiapoptotic genes: AATF (antiapoptosis-inducing
transcription factor) [31] and WFS1 (Wolfram syndrome 1) [24].
Genes implicated as being proapoptotic include: TRB3 (tribbles
homolog 3), which is downstream of CHOP [32] and ERO1 (ER
oxidase 1 alpha), which may exert proapoptotic effects by
stimulating inositol 1, 4, 5-triphophate receptors [33]. Another
gene with unchanged expression was ASNS (asparagine synthe-
tase), which can be activated by isoforms of AFT-3 [34]. A very
interesting change was an enormous increase in PCK1 (phospho-
enolpyruvate carboxykinase 1) in the transplanted beta cells. While
PCK1, a key enzyme for gluconeogenesis, has been linked to ER
stress, it is also known to be almost absent in beta cells, which have
little if any gluconeogenesis [35]. This change fits with the pattern
of phenotypic change seen with glucotoxicity [36].
Thus, the PERK arm of the ER stress response appears to be
mostly downregulated in transplanted islets. It is possible this is in
part due to increased expression of the PERK inhibitor DNAJC3
[15], which can be activated by both the IRE-1 and ATF6
pathways.
ATF-6 Pathway
As free levels of BiP decrease in the ER, ATF-6 translocates to
the Golgi apparatus where the active transcription factor
component, ATF-6a, is cleaved and released. ATF-6a then
translocates back to the nucleus where it works with cofactor
NFY (nuclear factor Y) to induce transcription of ER-associated
degradation proteins (HERP1, HERP2, ERO1), ER chaperone
proteins (BiP), pro-apoptotic gene products (CHOP), and PERK
inhibitor DNA-JC3 [7]. The data related to the ATF-6 pathway
are shown in Table 5. There was significantly decreased
expression of ATF-6 in the transplanted beta cells, as well as
downstream gene products CHOP and HERP2 (HEY1), which
can be activated by JNK. There was increased expression of
HRD1 (SYVN1, synovial apoptosis inhibitor 1), which exerts an
Table 3. IRE-1 Pathway.
Control Transplant
Probe ID Gene Name Value SE Value SE Fold Change LCB p-value
Hs.129166.0.A1_3p_at IRE-1 11 3 10 1 21.09 20.59 0.7862
g4827057_3p_s_at XBP1 4825 221 6970 261 1.44 1.3 0.0002
g7662001_3p_at EDEM1 317 34 205 27 21.54 21.17 0.0280
g8922666_3p_at EDEM2 126 4 176 15 1.39 1.16 0.0294
g13623480_3p_s_at PDIA4 212 35 1167 147 5.51 3.93 0.0010
Hs.75410.1.S1_3p_at BiP 644 41 1445 331 2.25 1.37 0.0617
g4507676_3p_a_at Grp94 3228 166 4347 309 1.35 1.14 0.0223
Hs2.429981.1.A1_3p_s_at DNAJC3 18 4 135 20 7.56 4.63 0.0016
Hs.267445.0.S2_3p_at JNK 181 19 73 18 22.48 21.67 0.002
g13376995_3p_at WFS1 210 19 203 20 21.03 20.81 0.835
g5262493_3p_a_at ERdj4 2464 209 4136 460 1.68 1.31 0.015
Hs.241576.0.S2_3p_at DERL1 899 49 598 101 21.5 21.15 0.032
Hs.14587.2.A1_3p_at DERL3 108 7 73 5 21.49 21.24 0.004
doi:10.1371/journal.pone.0011211.t003
ER Stress Response Beta Cells
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11211antiapoptotic effect by degrading unfolded proteins [37]. Para-
doxically, there was increased expression of DNAJC3. The ATF-6
pathway serves to protect the cell by increasing folding capacity as
well as to induce apoptosis if the folding capacity remains
overwhelmed. It appears that this pathway is down regulated
when beta cells are in a hyperglycemic environment.
Table 4. PERK Pathway Dataset.
Control Transplant
Probe ID Gene Name Value SE Value SE Fold Change LCB p-value
g11125767_3p_a_at PERK 1912 160 1956 162 1.02 0.83 0.8574
g13182760_3p_at EIF2A 1217 126 288 61 24.23 22.9 0.0002
g4502264_3p_at ATF4 3609 215 3842 241 1.06 0.9 0.5411
g4502262_3p_s_at ATF3 18 6 34 6 1.88 1.03 0.1099
g13177717_3p_at CHOP 348 43 159 26 22.19 21.57 0.0041
4901426C_3p_s_at GADD34 97 11 107 12 1.1 0.84 0.5526
Hs.17448.0.S1_3p_at CReP 509 46 220 44 22.31 21.66 0.0009
Hs.75410.1.S1_3p_at BiP 644 41 1445 331 2.25 1.37 0.0617
Hs2.429981.1.A1_3p_s_at DNAJC3 18 4 135 20 7.56 4.63 0.0016
g439225_3p_at FBP1 45 6 55 5 1.22 0.9 0.3094
g4511968_3p_a_at IRS2 1488 165 814 122 21.83 21.35 0.0085
g4505638_3p_a_at PCK1 172 53 2204 567 12.83 6.43 0.0164
Hs.146393.1.S1_3p_a_at HERP1 2783 117 2706 428 21.03 20.81 0.8689
Hs.30211.0.S2_3p_at HERP2 629 81 337 75 21.87 21.25 0.0250
g5453775_3p_at NRF2 699 60 259 44 22.7 21.99 0.0002
g4504170_3p_at GSTA1 16 7 105 40 6.74 2.14 0.0800
g4504436_3p_at HMOX 20 2 25 3 1.22 0.9 0.2951
g4505414_3p_a_at NQO1 215 21 131 5 21.64 21.32 0.0101
Hs.315562.0.A1_3p_at GCLM 229 30 118 21 21.94 21.34 0.0147
g11345419_3p_s_at Thioredoxin 455 27 184 21 22.48 22 0.0000
g5813798_3p_at AATF 572 49 434 90 21.32 20.94 0.218
g13376995_3p_at WFS1 210 19 203 20 21.03 20.81 0.835
g11056039_3p_at trb3 382 58 538 121 1.41 0.84 0.285
g4502258_3p_a_at ASNS 828 51 576 107 21.44 21.06 0.081
Hs.99029.0.S2_3p_at C/EBP-beta 103 8 46 4 22.23 21.83 0.000
Hs.7887.0.A1_3p_at C/EBP-gamma 80 10 50 10 21.6 21.1 0.064
g7657068_3p_a_at ERO1 139 13 155 17 1.12 0.86 0.495
doi:10.1371/journal.pone.0011211.t004
Table 5. ATF-6 Pathway Dataset.
Control Transplant
Probe ID Gene Name Value SE Value SE Fold Change LCB p-value
Hs.40328.0.A1_3p_at ATF6 309 15 207 26 21.49 21.19 0.0145
Hs.797.1.S3_3p_at NFY 94 22 52 6 21.81 21.08 0.1082
g13177717_3p_at CHOP 348 43 159 26 22.19 21.57 0.0041
Hs2.429981.1.A1_3p_s_at DNAJC3 18 4 135 20 7.56 4.63 0.0016
Hs.146393.1.S1_3p_a_at HERP1 2783 117 2706 428 21.03 20.81 0.8689
Hs.30211.0.S2_3p_at HERP2 629 81 337 75 21.87 21.25 0.0250
Hs.108689.0.A2_3p_at SREB2 16 2 16 4 21.02 20.61 0.9535
Hs.75410.1.S1_3p_at BiP 644 41 1445 331 2.25 1.37 0.0617
Hs.25740.0.S1_3p_a_at ERO1 169 21 169 27 1 20.7 0.9992
Hs.75859.1.A1_3p_at HRD1 105 6 183 24 1.75 1.33 0.024
doi:10.1371/journal.pone.0011211.t005
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The present study provides unique information about ER stress
in human beta cells exposed to hyperglycemia in an in vivo situation.
LCM was used on frozen sections to obtain beta cell rich tissue. To
avoid the potential artifacts of cadaver pancreases due to premorbid
illness and cold ischemia time, fresh tissue was obtained from
pancreases of non-diabetic subjects undergoing surgery. Gene
expression of these beta cells in the pancreas could then be
compared with human beta cells that were transplanted into mice.
Animportant pointisthat glucose levelsinmicearenaturallyhigher
than truly normal levels in humans; they are in the range of
impaired glucose tolerance or mild diabetes. Thus, these beta cells
are in a metabolic milieu similar to those in a liver site of patients
with successful islet transplants, who almost always have impaired
glucose tolerance rather than truly normal glucose levels [16]. We
know that beta cell function is adversely affected by glucose toxicity
even with these mild glucose elevations [6]. Thus, these compar-
isons make it possible to obtain insights into the ER stress response
in a transplant situation and with exposure to glucose toxicity.
However, from these experiments it is not possible to be certain
about how much differential expression is due to glucotoxicity
versusthat from the abnormal environmentofa graftsite.There are
certainly factors other than mild hyperglycemia that could have
accountedforthesegeneexpressionchanges.Beta cellsinagraft site
have reduced vascularization, exposure to relative hypoxia and
altered topographical relationships between beta and not beta cells
[38,39]. There could even be a variety of other perturbations such
as exposure of human cells to mouse serum.
There is great interest in the contributions of ER stress in beta
cells to the pathogenesis of diabetes and the failure of transplanted
human islets to maintain insulin secretion. It is important to
recognize the protective versus the destructive aspects for ER stress.
Much of the unfolded protein response (UPR) is protective in that
chaperones are induced, unfolded proteins are degraded and
protein synthesis is reduced. The IRE-1 pathway is particularly
important for this protective response [21]. However, when ER
stress becomes severe, apoptosis pathways can be induced, with
CHOP and JNK playing important roles. The most striking thing
about the present study is that beta cells in a transplant site exhibit
UPR with changes that should help the cells adapt to unfolded
proteins and to resist apoptosis. Of the three pathways of ER stress,
the IRE-1 pathway seems the most activated; the other pathways
have some variable results but seem mostly downregulated. It is
especially noteworthy that two factors well known to be associated
with apoptosis, CHOP and JNK, are downregulated.
These findings raise important questions about the relationship
between ER stress and beta cell death in diabetes. Beta cell death
elicited by cytokines and amyloid has been dissociated from ER
stress [40,41], but free fatty acid (FFA)-induced cell death in vitro
has been linked [42]. However, deleterious effects of FFA on beta
cells in diabetes remain to be established [6]. Beta cells in the
present study exposed to mild hyperglycemia have a clear UPR
response, which appears to be adaptive and protective against
excessive accumulation of unfolded proteins. It seems likely that
most beta cells have this UPR response and the only a small
minority of vulnerable cells die from the proapoptotic mechanisms
of ER stress. This hypothesis fits well with the finding that in
pancreases of subjects with type 2 diabetes, only rare beta cells are
stained for CHOP [12]. In summary, this study shows that human
beta cells in a transplant site have many changes in the expression
of ER stress genes. The most dominant changes are adaptive and
protective and not proapoptotic.
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